Overview
Thymoma Plasma
Thymoma Plasma is collected from IRB-consented donors diagnosed with clinically confirmed Thymoma. These plasma samples are ideal for evaluating cytokines and soluble markers involved in thymic neoplasms. Plasma supports research into systemic immune signaling, autoantibody presence, and tumor-derived exosomes.
Product Features
- Cryopreserved, clinically verified thymoma human plasma samples
- Cryopreserved to ensure stability and long-term storage
- Research Use Only (RUO)
Donor Metadata
- Clinically confirmed Thymoma diagnosis
- Donor demographics: age, sex assigned at birth, ethnicity
- Medical and treatment history available when applicable
Applications
- Evaluating cytokines and soluble markers involved in thymic neoplasms
- Biomarker discovery and validation
- Transcriptomic, proteomic, or functional studies
- Custom assay development and disease modeling
Compliance and Quality
- IRB-approved collection and electronic informed consent
- HIPAA-compliant donor data handling
Ordering and Customization
Thymoma Plasma is available in standard and custom volumes. Contact [email protected] for international requests or documentation needs.
Protocols and Documentation
Document Type | Technical Document |
---|---|
PDF > | Plasma Isolation |
Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.